ICU Medical (ICUI) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.37
- EPS estimate
- $1.91
- EPS surprise
- +23.85%
- Revenue surprise
- +2.71%
- Revenue
- $547.9M
- Revenue estimate
- $533.4M
- Reported
- Aug 6, 2026
ICU Medical reported Q2 2026 results on August 6, 2026. Earnings per share came in at $2.37, ahead of the $1.91 estimate by 23.85%. Revenue was $547.9 million, above the $533.4 million consensus by 2.71%. Compared with Q2 2025, EPS rose about 13% from $2.10, while revenue edged up about 1% from $543.6 million. The $2.37 result is the highest quarterly EPS in the table.
Earnings and revenue have moved in different directions. Annual EPS was $6.54 in 2022, $6.76 in 2023, $6.22 in 2024 and $7.76 in 2025. The first half of 2026 adds up to $4.34, about 14% more than the same period a year earlier. Revenue peaked at $621.6 million in Q4 2024 and has stayed between $525.8 million and $547.9 million over the last four quarters. ICU Medical topped the EPS estimate in 19 of the last 20 quarters. The only miss was Q2 2022, at 17.47% below.
The company reported its Q3 results between November 3 and November 12 in each of the past five years. That points to early or mid November 2026 for the next report. It will show whether the recent EPS gains continue.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $1.91 | $2.37 | +23.85% | $547.9M | SEC |
| Q1 2026 | May 7, 2026 | $1.75 | $1.97 | +12.42% | $525.8M | SEC |
| Q4 2025 | Feb 19, 2026 | $1.69 | $1.91 | +12.80% | $535.9M | SEC |
| Q3 2025 | Nov 6, 2025 | $1.43 | $2.03 | +41.54% | $533.3M | SEC |
| Q2 2025 | Aug 7, 2025 | $1.50 | $2.10 | +39.93% | $543.6M | SEC |
| Q1 2025 | May 8, 2025 | $1.28 | $1.72 | +34.38% | $599.5M | SEC |
| Q4 2024 | Feb 27, 2025 | $1.48 | $2.11 | +42.38% | $621.6M | SEC |
| Q3 2024 | Nov 12, 2024 | $1.25 | $1.59 | +27.23% | $580.1M | SEC |
| Q2 2024 | Aug 7, 2024 | $1.00 | $1.56 | +56.31% | $581.0M | SEC |
| Q1 2024 | May 7, 2024 | $0.82 | $0.96 | +17.07% | $566.7M | SEC |
| Q4 2023 | Feb 27, 2024 | $1.19 | $1.57 | +31.66% | $575.7M | SEC |
| Q3 2023 | Nov 6, 2023 | $1.39 | $1.57 | +13.36% | $546.6M | SEC |
| Q2 2023 | Aug 7, 2023 | $1.60 | $1.88 | +17.50% | $535.1M | SEC |
| Q1 2023 | May 8, 2023 | $1.43 | $1.74 | +21.96% | $555.9M | SEC |
| Q4 2022 | Feb 27, 2023 | $1.56 | $1.60 | +2.56% | $564.9M | SEC |
| Q3 2022 | Nov 7, 2022 | $1.46 | $1.75 | +19.59% | $582.1M | SEC |
| Q2 2022 | Aug 8, 2022 | $1.66 | $1.37 | −17.47% | $547.0M | SEC |
| Q1 2022 | May 9, 2022 | $1.80 | $1.82 | +1.11% | $532.1M | SEC |
| Q4 2021 | Feb 24, 2022 | $1.64 | $1.82 | +10.75% | $329.9M | SEC |
| Q3 2021 | Nov 3, 2021 | $1.80 | $2.07 | +15.21% | $336.1M | SEC |
Quarterly revenue
Frequently asked questions
When did ICU Medical (ICUI) last report earnings?
ICU Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did ICUI beat earnings estimates?
Yes. ICU Medical reported EPS of $2.37 for Q2 2026 against a $1.91 estimate — a 23.85% beat.
How much revenue did ICUI report last quarter?
ICU Medical reported $547.9M in revenue for Q2 2026, against a consensus estimate of $533.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.